首页 > 最新文献

Technical Innovations and Patient Support in Radiation Oncology最新文献

英文 中文
What does “Advanced” mean in 2023? reflecting on 10 years of the ESTRO advanced Skills in modern radiotherapy course 2023 年的 "高级 "意味着什么?ESTRO 现代放射治疗高级技能课程 10 年回顾
Q1 Nursing Pub Date : 2023-12-01 DOI: 10.1016/j.tipsro.2023.100227
E. Forde , M. Josipovic , M. Kamphuis , J. Lopez , P. Remeijer , S. Rivera , P. Scherer , L. Wiersema , R. de Jong

The roles and responsibilities of radiation therapists (RTTs) are many and varied. Professional expectations are influenced by the technology available, as well as the level of autonomy RTTs have in their daily practice. This professional range requires RTTs to possess a unique set of ever evolving skills, posing challenges from an educational perspective.

Teaching these “advanced skills” has been the ambition the ESTRO Advanced Skills in Modern Radiotherapy course. In the 10th year of this course, the Faculty look back and reflect on how our programme has evolved and what it has achieved.

放射治疗师(rtt)的角色和职责是多种多样的。专业期望受到可用技术以及rtt在日常实践中的自主水平的影响。这个专业范围要求rtt拥有一套独特的不断发展的技能,从教育的角度提出了挑战。教授这些“高级技能”一直是ESTRO现代放射治疗高级技能课程的目标。在这门课程的第10个年头,学院回顾并反思了我们的课程是如何发展的以及它取得了什么成就。
{"title":"What does “Advanced” mean in 2023? reflecting on 10 years of the ESTRO advanced Skills in modern radiotherapy course","authors":"E. Forde ,&nbsp;M. Josipovic ,&nbsp;M. Kamphuis ,&nbsp;J. Lopez ,&nbsp;P. Remeijer ,&nbsp;S. Rivera ,&nbsp;P. Scherer ,&nbsp;L. Wiersema ,&nbsp;R. de Jong","doi":"10.1016/j.tipsro.2023.100227","DOIUrl":"https://doi.org/10.1016/j.tipsro.2023.100227","url":null,"abstract":"<div><p>The roles and responsibilities of radiation therapists (RTTs) are many and varied. Professional expectations are influenced by the technology available, as well as the level of autonomy RTTs have in their daily practice. This professional range requires RTTs to possess a unique set of ever evolving skills, posing challenges from an educational perspective.</p><p>Teaching these “advanced skills” has been the ambition the ESTRO Advanced Skills in Modern Radiotherapy course. In the 10th year of this course, the Faculty look back and reflect on how our programme has evolved and what it has achieved.</p></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405632423000276/pdfft?md5=4ffb8b35da01723985ab31f5aeb7b8e9&pid=1-s2.0-S2405632423000276-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138678405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experiences implementing a Radiation therapist-led oncology prehabilitation program during COVID-19 在COVID-19期间实施放射治疗师主导的肿瘤康复计划的经验
Q1 Nursing Pub Date : 2023-11-30 DOI: 10.1016/j.tipsro.2023.100226
Erica Bennett , Trish Clifford , Fiona Cregan , Ellen O'Neill , Donna Spillane , Kieran Harte , Mary Hickey , Paul J Kelly
{"title":"Experiences implementing a Radiation therapist-led oncology prehabilitation program during COVID-19","authors":"Erica Bennett ,&nbsp;Trish Clifford ,&nbsp;Fiona Cregan ,&nbsp;Ellen O'Neill ,&nbsp;Donna Spillane ,&nbsp;Kieran Harte ,&nbsp;Mary Hickey ,&nbsp;Paul J Kelly","doi":"10.1016/j.tipsro.2023.100226","DOIUrl":"https://doi.org/10.1016/j.tipsro.2023.100226","url":null,"abstract":"","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405632423000264/pdfft?md5=05eaed772657f6bdf921445f796162de&pid=1-s2.0-S2405632423000264-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138480507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving referral rates for smoking cessation: A multifaceted intervention aimed at radiation oncologists 提高戒烟转诊率:针对放射肿瘤科医生的多方面干预措施
Q1 Nursing Pub Date : 2023-11-25 DOI: 10.1016/j.tipsro.2023.100225
Iris Bronsema , Luc van Lonkhuijzen , Peter Scholten , Janna Laan , Henrike Westerveld , Lukas Stalpers

Objective

Continuation of smoking after a cancer diagnosis increases the burdensome side effects from cancer treatment, and decreases the chances of cure. Smoking cessation may improve oncological outcomes in cancer patients. This study aims to evaluate if radiation oncologists can be motivated by a smoking cessation awareness intervention to discuss smoking status more frequently and increase the referral rate for smoking cessation-support.

Study design and Setting:

A multifaceted approach was used to improve awareness: First, current practice was evaluated by a retrospective chart review of 282 patients referred for radiotherapy to ascertain smoking status, discussion of smoking cessation support and referral rates. Secondly, radiation oncologists were interviewed about their motives and barriers to discuss smoking status and smoking cessation support. The results were fed back in a teaching lecture to the doctors involved. Finally, the effect of this smoking cessation awareness intervention was prospectively evaluated in 100 patients.

Results

After the smoking cessation awareness intervention, smoking cessation was more frequently discussed compared to baseline (77% (10/13)) and 39.5% (17/43) respectively. The referral rate for smoking cessation increased from 2.3% (1/43) to 69.2% (9/13)

Conclusion

Without an active smoking prevention awareness policy, referral for smoking cessation support for cancer patients by radiation oncologists is low. A relatively short and simple smoking awareness intervention for radiation oncologist may result in a more frequent discussion with patients about smoking cessation and an even larger increase in referrals for smoking cessation support.

目的癌症诊断后继续吸烟增加了癌症治疗的副作用,降低了治愈的机会。戒烟可以改善癌症患者的肿瘤预后。本研究旨在评估放射肿瘤学家是否可以通过戒烟意识干预来更频繁地讨论吸烟状况,并提高戒烟支持的转诊率。研究设计和背景:采用多方面的方法来提高认识:首先,通过对282例转诊放疗患者的回顾性图表回顾来评估当前的做法,以确定吸烟状况,讨论戒烟支持和转诊率。其次,对放射肿瘤学家进行访谈,了解他们讨论吸烟状况和戒烟支持的动机和障碍。研究结果在教学讲座中反馈给了相关医生。最后,在100名患者中对这种戒烟意识干预的效果进行了前瞻性评估。结果戒烟意识干预后,与基线相比,戒烟的讨论频率分别为77%(10/13)和39.5%(17/43)。戒烟转诊率由2.3%(1/43)上升至69.2%(9/13)。结论在没有积极的预防吸烟意识政策的情况下,放射肿瘤学家对癌症患者戒烟支持的转诊率较低。对于放射肿瘤学家来说,一个相对短而简单的吸烟意识干预可能会导致与患者更频繁地讨论戒烟问题,甚至更大程度上增加戒烟支持的转诊。
{"title":"Improving referral rates for smoking cessation: A multifaceted intervention aimed at radiation oncologists","authors":"Iris Bronsema ,&nbsp;Luc van Lonkhuijzen ,&nbsp;Peter Scholten ,&nbsp;Janna Laan ,&nbsp;Henrike Westerveld ,&nbsp;Lukas Stalpers","doi":"10.1016/j.tipsro.2023.100225","DOIUrl":"https://doi.org/10.1016/j.tipsro.2023.100225","url":null,"abstract":"<div><h3>Objective</h3><p>Continuation of smoking after a cancer diagnosis increases the burdensome side effects from cancer treatment, and decreases the chances of cure. Smoking cessation may improve oncological outcomes in cancer patients. This study aims to evaluate if radiation oncologists can be motivated by a smoking cessation awareness intervention to discuss smoking status more frequently and increase the referral rate for smoking cessation-support.</p><p>Study design and Setting:</p><p>A multifaceted approach was used to improve awareness: First, current practice was evaluated by a retrospective chart review of 282 patients referred for radiotherapy to ascertain smoking status, discussion of smoking cessation support and referral rates. Secondly, radiation oncologists were interviewed about their motives and barriers to discuss smoking status and smoking cessation support. The results were fed back in a teaching lecture to the doctors involved. Finally, the effect of this smoking cessation awareness intervention was prospectively evaluated in 100 patients.</p></div><div><h3>Results</h3><p>After the smoking cessation awareness intervention, smoking cessation was more frequently discussed compared to baseline (77% (10/13)) and 39.5% (17/43) respectively. The referral rate for smoking cessation increased from 2.3% (1/43) to 69.2% (9/13)</p></div><div><h3>Conclusion</h3><p>Without an active smoking prevention awareness policy, referral for smoking cessation support for cancer patients by radiation oncologists is low. A relatively short and simple smoking awareness intervention for radiation oncologist may result in a more frequent discussion with patients about smoking cessation and an even larger increase in referrals for smoking cessation support.</p></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405632423000252/pdfft?md5=4b0b79957d025903f572c8fdb1fe58f1&pid=1-s2.0-S2405632423000252-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138678335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient expectation and experience of MR-guided radiotherapy using a 1.5T MR-Linac 患者对使用 1.5T MR-Linac 进行磁共振引导放射治疗的期望和体验
Q1 Nursing Pub Date : 2023-11-25 DOI: 10.1016/j.tipsro.2023.100224
S.R. de Mol van Otterloo , J.M. Westerhoff , T. Leer , R.H.A. Rutgers , L.T.C. Meijers , L.A. Daamen , M.P.W. Intven , H.M. Verkooijen

Background and Purpose

Online adaptive MR-guided radiotherapy (MRgRT) is a relatively new form of radiotherapy treatment, delivered using a MR-Linac. It is unknown what patients expect from this treatment and whether these expectations are met. This study evaluates whether patients’ pre-treatment expectations of MRgRT are met and reports patients’ on-table experience on a 1.5 T MR-Linac.

Materials and methods

All patients treated on the MR-Linac from November 2020 until April 2021, were eligible for inclusion. Patient expectation and experience were captured through questionnaires before, during, and three months after treatment. The on-table experience questionnaire included patient’ physical and psychological coping. Patient-expected side effects, participation in daily and social activity, disease outcome and, disease related symptoms were compared to post-treatment experience.

Results

We included 113 patients who were primarily male (n = 100, 89 %), with a median age of 69 years (range 52–90). For on-table experience, ninety percent of patients (strongly) agreed to feeling calm during their treatment. Six and eight percent of patients found the treatment position or bed uncomfortable respectively. Twenty-eight percent of patients felt tingling sensations during treatment. After treatment, 79 % of patients’ expectations were met. Most patients experienced an (better than) expected level of side effects (75 %), participation in daily- (83 %) and social activity (86 %) and symptoms (78 %). However, 33 % expected more treatment efficacy than experienced.

Conclusion

Treatment on the 1.5 T MR-Linac is well tolerated and meets patient expectations. Despite the fact that some patients expected greater treatment efficacy and the frequent occurrence of tingling sensations during treatment, most patient experiences were comparable or better than previously expected.

背景和目的在线自适应磁共振引导放疗(MRgRT)是一种相对较新的放疗方式,使用磁共振Linac进行放疗。目前尚不清楚患者对这种治疗的期望以及这些期望是否得到满足。本研究评估了患者在治疗前对 MRgRT 的期望是否得到满足,并报告了患者在 1.5 T MR-Linac 上的治疗体验。材料和方法所有在 2020 年 11 月至 2021 年 4 月期间接受 MR-Linac 治疗的患者均符合纳入条件。在治疗前、治疗中和治疗后三个月,通过问卷调查了解患者的期望和体验。现场体验问卷包括患者的生理和心理应对情况。患者的预期副作用、参与日常和社会活动的情况、疾病结果和疾病相关症状与治疗后的体验进行了比较。 结果 我们纳入了 113 名患者,他们主要为男性(n = 100,89%),中位年龄为 69 岁(52-90 岁不等)。在台上体验方面,90% 的患者(强烈)同意在治疗过程中感到平静。分别有 6% 和 8% 的患者认为治疗姿势或床不舒服。28%的患者在治疗过程中感到刺痛。治疗后,79% 的患者达到了预期效果。大多数患者在副作用(75%)、参与日常活动(83%)和社交活动(86%)以及症状(78%)方面的体验(好于)预期水平。结论1.5 T MR-Linac 治疗的耐受性良好,符合患者的期望。尽管一些患者期望获得更高的疗效,而且在治疗过程中经常出现刺痛感,但大多数患者的体验与之前的预期相当或更好。
{"title":"Patient expectation and experience of MR-guided radiotherapy using a 1.5T MR-Linac","authors":"S.R. de Mol van Otterloo ,&nbsp;J.M. Westerhoff ,&nbsp;T. Leer ,&nbsp;R.H.A. Rutgers ,&nbsp;L.T.C. Meijers ,&nbsp;L.A. Daamen ,&nbsp;M.P.W. Intven ,&nbsp;H.M. Verkooijen","doi":"10.1016/j.tipsro.2023.100224","DOIUrl":"https://doi.org/10.1016/j.tipsro.2023.100224","url":null,"abstract":"<div><h3>Background and Purpose</h3><p>Online adaptive MR-guided radiotherapy (MRgRT) is a relatively new form of radiotherapy treatment, delivered using a MR-Linac. It is unknown what patients expect from this treatment and whether these expectations are met. This study evaluates whether patients’ pre-treatment expectations of MRgRT are met and reports patients’ on-table experience on a 1.5 T MR-Linac.</p></div><div><h3>Materials and methods</h3><p>All patients treated on the MR-Linac from November 2020 until April 2021, were eligible for inclusion. Patient expectation and experience were captured through questionnaires before, during, and three months after treatment. The on-table experience questionnaire included patient’ physical and psychological coping. Patient-expected side effects, participation in daily and social activity, disease outcome and, disease related symptoms were compared to post-treatment experience.</p></div><div><h3>Results</h3><p>We included 113 patients who were primarily male (n = 100, 89 %), with a median age of 69 years (range 52–90). For on-table experience, ninety percent of patients (strongly) agreed to feeling calm during their treatment. Six and eight percent of patients found the treatment position or bed uncomfortable respectively. Twenty-eight percent of patients felt tingling sensations during treatment. After treatment, 79 % of patients’ expectations were met. Most patients experienced an (better than) expected level of side effects (75 %), participation in daily- (83 %) and social activity (86 %) and symptoms (78 %). However, 33 % expected more treatment efficacy than experienced.</p></div><div><h3>Conclusion</h3><p>Treatment on the 1.5 T MR-Linac is well tolerated and meets patient expectations. Despite the fact that some patients expected greater treatment efficacy and the frequent occurrence of tingling sensations during treatment, most patient experiences were comparable or better than previously expected.</p></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405632423000240/pdfft?md5=b9079f66d3a5754664a706af43d1b2c8&pid=1-s2.0-S2405632423000240-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138558647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and tolerability of breath-hold in liver stereotactic body radiotherapy with surface guided radiotherapy 表面引导下肝立体定向放射治疗中屏气的可行性和耐受性
Q1 Nursing Pub Date : 2023-11-23 DOI: 10.1016/j.tipsro.2023.100223
Menekse Turna, Esra Küçükmorkoç, Rashad Rzazade, Mehmet Doğu Canoğlu, Nadir Küçük, Hale Basak Caglar

Purpose

Intrafractional motion constitutes a significant challenge in SBRT (Stereotactic Body Radiotherapy).The breath-hold (BH) technique is employed to mitigate tumor motion; however, ensuring reproducibility and consistency remains critically important. Surface tracking systems, integrated into the treatment process, facilitate motion tracking through three-dimensional camera technology. Surface guidance has been incorporated with Varian EDGE (Varian Medical Systems, Palo Alto, CA, USA) and has been utilized at multiple treatment sites within our department since 2018. Drawing on four years of experience, this study aims to publish patient experience, assess the feasibility, and evaluate the tolerability of breath-hold during SBRT with surface guided radiotherapy (SGRT), particularly focusing on a specific subgroup: patients with liver metastases.

Methods

Prospective evaluation was conducted on patients with liver metastases undergoing breath-hold SBRT with SGRT. A two-step survey consisting of seven questions was administered after CT simulation and treatment. Treatment duration and the number of breath-holds were recorded. Additionally, factors potentially influencing SGRT and treatment time were assessed.

Results

Between April 2021 and May 2022, a total of 41 patients underwent 171 fractions of treatment. According to the questionnaire, prior training was found to be beneficial, and breath-holding during the procedure was tolerable. Patients reported experiencing slight stress due to their active participation in the treatment. Factors such as Karnofsky Performance Status (KPS), age, lung volume, conditions affecting lung capacity, previous breath-hold history, and being a native speaker showed no correlation with treatment time. Moreover, these factors did not correlate with the tolerability of breath-hold during SGRT. However, female patients showed better breath-holding performance in SGRT treatments compared to male patients (p: 0.02).

Conclusions

The application of breath-hold with SGRT procedures is tolerable and feasible in liver SBRT treatments. There exists no specific subgroup that cannot tolerate this method.

目的:在立体定向放射治疗中,病灶内运动是一个重大的挑战。采用屏气(BH)技术缓解肿瘤运动;然而,确保可重复性和一致性仍然至关重要。表面跟踪系统,集成到处理过程中,便于通过三维相机技术进行运动跟踪。表面引导已与Varian EDGE (Varian Medical Systems, Palo Alto, CA, USA)结合,自2018年以来已在我们部门的多个治疗地点使用。基于四年的经验,本研究旨在发表患者经验,评估SBRT联合表面引导放疗(SGRT)期间屏气的可行性,并评估其耐受性,特别关注一个特定的亚组:肝转移患者。方法对肝转移患者行屏气SBRT联合SGRT进行前瞻性评价。在CT模拟和治疗后进行了包括七个问题的两步调查。记录治疗时间和屏气次数。此外,还评估了可能影响SGRT和治疗时间的因素。结果在2021年4月至2022年5月期间,共有41名患者接受了171次治疗。根据问卷调查,先前的训练被发现是有益的,在手术过程中屏气是可以容忍的。患者报告说,由于他们积极参与治疗,他们感到轻微的压力。Karnofsky Performance Status (KPS)、年龄、肺容量、影响肺活量的条件、以前的屏气史、是否是母语者等因素与治疗时间没有相关性。此外,这些因素与SGRT期间的屏气耐受性无关。然而,与男性患者相比,女性患者在SGRT治疗中表现出更好的屏气性能(p: 0.02)。结论在肝脏SBRT治疗中应用屏气联合SGRT是可耐受的、可行的。不存在不能容忍这种方法的特定子组。
{"title":"Feasibility and tolerability of breath-hold in liver stereotactic body radiotherapy with surface guided radiotherapy","authors":"Menekse Turna,&nbsp;Esra Küçükmorkoç,&nbsp;Rashad Rzazade,&nbsp;Mehmet Doğu Canoğlu,&nbsp;Nadir Küçük,&nbsp;Hale Basak Caglar","doi":"10.1016/j.tipsro.2023.100223","DOIUrl":"https://doi.org/10.1016/j.tipsro.2023.100223","url":null,"abstract":"<div><h3>Purpose</h3><p>Intrafractional motion constitutes a significant challenge in SBRT (Stereotactic Body Radiotherapy).The breath-hold (BH) technique is employed to mitigate tumor motion; however, ensuring reproducibility and consistency remains critically important. Surface tracking systems, integrated into the treatment process, facilitate motion tracking through three-dimensional camera technology. Surface guidance has been incorporated with Varian EDGE (Varian Medical Systems, Palo Alto, CA, USA) and has been utilized at multiple treatment sites within our department since 2018. Drawing on four years of experience, this study aims to publish patient experience, assess the feasibility, and evaluate the tolerability of breath-hold during SBRT with surface guided radiotherapy (SGRT), particularly focusing on a specific subgroup: patients with liver metastases.</p></div><div><h3>Methods</h3><p>Prospective evaluation was conducted on patients with liver metastases undergoing breath-hold SBRT with SGRT. A two-step survey consisting of seven questions was administered after CT simulation and treatment. Treatment duration and the number of breath-holds were recorded. Additionally, factors potentially influencing SGRT and treatment time were assessed.</p></div><div><h3>Results</h3><p>Between April 2021 and May 2022, a total of 41 patients underwent 171 fractions of treatment. According to the questionnaire, prior training was found to be beneficial, and breath-holding during the procedure was tolerable. Patients reported experiencing slight stress due to their active participation in the treatment. Factors such as Karnofsky Performance Status (KPS), age, lung volume, conditions affecting lung capacity, previous breath-hold history, and being a native speaker showed no correlation with treatment time. Moreover, these factors did not correlate with the tolerability of breath-hold during SGRT. However, female patients showed better breath-holding performance in SGRT treatments compared to male patients (p: 0.02).</p></div><div><h3>Conclusions</h3><p>The application of breath-hold with SGRT procedures is tolerable and feasible in liver SBRT treatments. There exists no specific subgroup that cannot tolerate this method.</p></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405632423000239/pdfft?md5=61baca190cdcef7749f12984661667f3&pid=1-s2.0-S2405632423000239-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138453823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodal treatment with chemoradiotherapy, regional hyperthermia and interstitial brachytherapy for a huge locally advanced cervical cancer: A case report 放化疗、局部热疗及间质性近距离放射治疗巨大局部晚期宫颈癌1例
Q1 Nursing Pub Date : 2023-11-18 DOI: 10.1016/j.tipsro.2023.100222
Takashi Saito , Motohiro Murakami , Taisuke Sumiya , Daisuke Kobayashi , Haruka Shirataki , Den Fujioka , Keiichiro Baba , Hiroya Itagaki , Yuri Tenjimbayashi , Toyomi Satoh , Hideyuki Sakurai

A female patient in her 50 s was found to have a 10-cm tumor resulting from locally advanced cervical cancer (LACC). Three-year relapse-free survival was achieved following a multimodal treatment strategy integrating chemoradiotherapy (CRT), regional hyperthermia (RHT), and interstitial brachytherapy (ISBT). Given the large size of the tumor, enhancement of the geometrical dose distribution was anticipated using ISBT. However, delivery of a sufficient dose to the high-risk clinical target volume was predicted to be challenging. Thus, RHT was incorporated to potentially augment the overall treatment effect. This unique combination of CRT, RHT and ISBT may be promising for management of large LACC and warrants further investigation.

一位50多岁的女性患者被发现有一个10厘米的肿瘤,由局部晚期宫颈癌(LACC)引起。通过综合放化疗(CRT)、局部热疗(RHT)和间质近距离放射治疗(ISBT)的多模式治疗策略,实现了三年无复发生存期。考虑到肿瘤的大尺寸,预期使用ISBT可以增强几何剂量分布。然而,预计向高风险临床靶体积递送足够剂量是具有挑战性的。因此,纳入RHT可能会增加整体治疗效果。CRT, RHT和ISBT的独特组合可能对大型LACC的治疗有希望,值得进一步研究。
{"title":"Multimodal treatment with chemoradiotherapy, regional hyperthermia and interstitial brachytherapy for a huge locally advanced cervical cancer: A case report","authors":"Takashi Saito ,&nbsp;Motohiro Murakami ,&nbsp;Taisuke Sumiya ,&nbsp;Daisuke Kobayashi ,&nbsp;Haruka Shirataki ,&nbsp;Den Fujioka ,&nbsp;Keiichiro Baba ,&nbsp;Hiroya Itagaki ,&nbsp;Yuri Tenjimbayashi ,&nbsp;Toyomi Satoh ,&nbsp;Hideyuki Sakurai","doi":"10.1016/j.tipsro.2023.100222","DOIUrl":"https://doi.org/10.1016/j.tipsro.2023.100222","url":null,"abstract":"<div><p>A female patient in her 50 s was found to have a 10-cm tumor resulting from locally advanced cervical cancer (LACC). Three-year relapse-free survival was achieved following a multimodal treatment strategy integrating chemoradiotherapy (CRT), regional hyperthermia (RHT), and interstitial brachytherapy (ISBT). Given the large size of the tumor, enhancement of the geometrical dose distribution was anticipated using ISBT. However, delivery of a sufficient dose to the high-risk clinical target volume was predicted to be challenging. Thus, RHT was incorporated to potentially augment the overall treatment effect. This unique combination of CRT, RHT and ISBT may be promising for management of large LACC and warrants further investigation.</p></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405632423000227/pdfft?md5=d5e62e8806cdab719d2f44f9cfc95490&pid=1-s2.0-S2405632423000227-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138395503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dosimetric and radiobiological analyses of a de-escalation strategy for elective nodal regions in human papillomavirus-associated oropharyngeal cancer 人乳头瘤病毒相关口咽癌症选择性淋巴结区域去标策略的剂量测定和放射生物学分析
Q1 Nursing Pub Date : 2023-10-13 DOI: 10.1016/j.tipsro.2023.100221
Natsuo Tomita , Naoki Hayashi , Tomoki Mizuno , Yuto Kitagawa , Keisuke Yasui , Yasunori Saito , Shuo Sudo , Seiya Takano , Nozomi Kita , Akira Torii , Masanari Niwa , Dai Okazaki , Taiki Takaoka , Daisuke Kawakita , Shinichi Iwasaki , Akio Hiwatashi

Introduction

In this simulation study, we examined the effects of a de-escalation strategy with a reduced dose to subclinical nodal regions in patients with human papillomavirus (HPV)-associated oropharyngeal carcinoma (OPC).

Methods

We created two patterns of intensity-modulated radiotherapy for 16 patients with HPV-associated OPC. In the standard and de-escalation plans, the initial field including elective nodal regions received 46 and 30 Gy, followed by 20 and 36 Gy to the cutdown field, respectively. Comparison metrics were set for each organ at risk (OAR). We compared these metric values and the probability of adverse effects based on the normal tissue complication probability (NTCP) model between the two plans.

Results

Both plans generally met the dose constraints for the targets and all OAR. Among the comparison metrics, the mean doses to the brain, pharyngeal constrictor muscle, thyroid, and skin and the dose to a 1 % volume of the skin were higher in the standard plan than in the de-escalation plan (P = 0.031, 0.007, < 0.001, < 0.001, and 0.006, respectively). NTCP analyses revealed that the probability of adverse effects in the ipsilateral parotid gland and thyroid was higher in the standard plan than in the de-escalation plan (standard vs. de-escalation plans: ipsilateral parotid gland, 6.4 % vs. 5.0 %, P = 0.016; thyroid, 3.3 % vs. 0.5 %, P < 0.001).

Conclusions

A de-escalation strategy with elective nodal regions is a promising treatment to prevent a decline in the quality of life in patients with HPV-associated OPC, particularly xerostomia, dysphagia, and hypothyroidism.

引言在这项模拟研究中,我们检测了在人乳头瘤病毒(HPV)相关口咽癌(OPC)患者的亚临床淋巴结区域减少剂量的降级策略的效果。在标准和降级计划中,包括选择性淋巴结区域的初始场分别接受46和30 Gy,然后分别接受20和36 Gy的向下场。为每个有风险的器官(OAR)设置比较指标。我们比较了这两种方案之间基于正常组织并发症概率(NTCP)模型的这些度量值和不良反应概率。结果两种方案总体上都符合目标和所有OAR的剂量限制。在比较指标中,标准方案中对大脑、咽收缩肌、甲状腺和皮肤的平均剂量以及对1%体积皮肤的剂量高于降级方案(分别为P=0.031、0.007、<;0.001、<!0.001和0.006)。NTCP分析显示,标准方案对同侧腮腺和甲状腺产生不良反应的概率高于降级方案(标准方案与降级方案:同侧腮腺,6.4%vs.5.0%,P=0.016;甲状腺,3.3%vs.0.5%,P<;0.001)以防止HPV相关OPC患者的生活质量下降,特别是口干、吞咽困难和甲状腺功能减退。
{"title":"Dosimetric and radiobiological analyses of a de-escalation strategy for elective nodal regions in human papillomavirus-associated oropharyngeal cancer","authors":"Natsuo Tomita ,&nbsp;Naoki Hayashi ,&nbsp;Tomoki Mizuno ,&nbsp;Yuto Kitagawa ,&nbsp;Keisuke Yasui ,&nbsp;Yasunori Saito ,&nbsp;Shuo Sudo ,&nbsp;Seiya Takano ,&nbsp;Nozomi Kita ,&nbsp;Akira Torii ,&nbsp;Masanari Niwa ,&nbsp;Dai Okazaki ,&nbsp;Taiki Takaoka ,&nbsp;Daisuke Kawakita ,&nbsp;Shinichi Iwasaki ,&nbsp;Akio Hiwatashi","doi":"10.1016/j.tipsro.2023.100221","DOIUrl":"https://doi.org/10.1016/j.tipsro.2023.100221","url":null,"abstract":"<div><h3>Introduction</h3><p>In this simulation study, we examined the effects of a de-escalation strategy with a reduced dose to subclinical nodal regions in patients with human papillomavirus (HPV)-associated oropharyngeal carcinoma (OPC).</p></div><div><h3>Methods</h3><p>We created two patterns of intensity-modulated radiotherapy for 16 patients with HPV-associated OPC. In the standard and de-escalation plans, the initial field including elective nodal regions received 46 and 30 Gy, followed by 20 and 36 Gy to the cutdown field, respectively. Comparison metrics were set for each organ at risk (OAR). We compared these metric values and the probability of adverse effects based on the normal tissue complication probability (NTCP) model between the two plans.</p></div><div><h3>Results</h3><p>Both plans generally met the dose constraints for the targets and all OAR. Among the comparison metrics, the mean doses to the brain, pharyngeal constrictor muscle, thyroid, and skin and the dose to a 1 % volume of the skin were higher in the standard plan than in the de-escalation plan (<em>P</em> = 0.031, 0.007, &lt; 0.001, &lt; 0.001, and 0.006, respectively). NTCP analyses revealed that the probability of adverse effects in the ipsilateral parotid gland and thyroid was higher in the standard plan than in the de-escalation plan (standard vs. de-escalation plans: ipsilateral parotid gland, 6.4 % vs. 5.0 %, <em>P</em> = 0.016; thyroid, 3.3 % vs. 0.5 %, <em>P</em> &lt; 0.001).</p></div><div><h3>Conclusions</h3><p>A de-escalation strategy with elective nodal regions is a promising treatment to prevent a decline in the quality of life in patients with HPV-associated OPC, particularly xerostomia, dysphagia, and hypothyroidism.</p></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49791499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cone-beam computed tomography-guided online-adaptive radiotherapy for inoperable right colon cancer: First in human 锥束计算机断层扫描引导下的在线自适应放疗治疗不能手术的右结肠癌:首次在人类中应用
Q1 Nursing Pub Date : 2023-09-26 DOI: 10.1016/j.tipsro.2023.100220
Julien Pierrard , Damien Dumont , David Dechambre , Marc Van den Eynde , Astrid De Cuyper , Geneviève Van Ooteghem

We report the case of a medically inoperable patient with localised colon cancer. Due to symptomatic bleeding, definitive radiotherapy (5 daily fractions of 5 Gy) has been performed using cone-beam computed tomography-based online-adaptive radiotherapy (ART). Online-ART enables compensation of interfraction motion of abdominal organs by performing daily delineation of organs at risk (OARs) and target volumes. Daily treatment replanning maximised target volume coverage while lowering the dose to OARs. Intrafraction variation of the tumour was still significant and had to be incorporated in the planning target volume margin computation. After the treatment, the patient did not develop any acute radiotherapy-induced adverse events and had no further rectal bleeding either at the end of the radiotherapy or at oncological follow-up 4 months later. Online-ART for colon cancer is feasible and is a valuable alternative when surgery is not an option.

我们报告了一例因局部结肠癌癌症而无法手术的患者。由于症状性出血,使用基于锥束计算机断层扫描的在线自适应放射治疗(ART)进行了明确的放射治疗(每天5次,每次5 Gy)。在线ART能够通过每天描绘危险器官(OAR)和目标体积来补偿腹部器官的交叉运动。每日治疗重新规划最大限度地扩大了目标体积覆盖范围,同时将剂量降至OARs。肿瘤的分数内变异仍然显著,必须纳入计划目标体积裕度计算中。治疗后,患者没有出现任何急性放疗引起的不良事件,在放疗结束时或4个月后的肿瘤学随访中也没有进一步的直肠出血。Online-ART治疗结肠癌癌症是可行的,并且在不能选择手术的情况下是一种有价值的替代方案。
{"title":"Cone-beam computed tomography-guided online-adaptive radiotherapy for inoperable right colon cancer: First in human","authors":"Julien Pierrard ,&nbsp;Damien Dumont ,&nbsp;David Dechambre ,&nbsp;Marc Van den Eynde ,&nbsp;Astrid De Cuyper ,&nbsp;Geneviève Van Ooteghem","doi":"10.1016/j.tipsro.2023.100220","DOIUrl":"10.1016/j.tipsro.2023.100220","url":null,"abstract":"<div><p>We report the case of a medically inoperable patient with localised colon cancer. Due to symptomatic bleeding, definitive radiotherapy (5 daily fractions of 5 Gy) has been performed using cone-beam computed tomography-based online-adaptive radiotherapy (ART). Online-ART enables compensation of interfraction motion of abdominal organs by performing daily delineation of organs at risk (OARs) and target volumes. Daily treatment replanning maximised target volume coverage while lowering the dose to OARs. Intrafraction variation of the tumour was still significant and had to be incorporated in the planning target volume margin computation. After the treatment, the patient did not develop any acute radiotherapy-induced adverse events and had no further rectal bleeding either at the end of the radiotherapy or at oncological follow-up 4 months later. Online-ART for colon cancer is feasible and is a valuable alternative when surgery is not an option.</p></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a6/97/main.PMC10565851.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41223052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ESTRO-ACROP guideline for positioning, immobilisation and setup verification for local and loco-regional photon breast cancer irradiation 局部和局部区域光子乳腺癌照射的定位,固定和设置验证的ESTRO-ACROP指南
Q1 Nursing Pub Date : 2023-09-12 DOI: 10.1016/j.tipsro.2023.100219
M.E. Mast , A. Leong , S.S. Korreman , G. Lee , H. Probst , P. Scherer , Y. Tsang
{"title":"ESTRO-ACROP guideline for positioning, immobilisation and setup verification for local and loco-regional photon breast cancer irradiation","authors":"M.E. Mast ,&nbsp;A. Leong ,&nbsp;S.S. Korreman ,&nbsp;G. Lee ,&nbsp;H. Probst ,&nbsp;P. Scherer ,&nbsp;Y. Tsang","doi":"10.1016/j.tipsro.2023.100219","DOIUrl":"10.1016/j.tipsro.2023.100219","url":null,"abstract":"","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e0/ab/main.PMC10511493.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41136742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Triage for palliative radiotherapy by clinical specialist radiation therapists: A scoping review 临床专业放射治疗师对姑息性放射治疗的分类:范围界定综述。
Q1 Nursing Pub Date : 2023-09-01 DOI: 10.1016/j.tipsro.2023.100213
Pamela Paterson , Alysa Fairchild

Patients who could benefit from palliative radiotherapy (PRT) may be in different phases of the cancer journey: they may have minimal symptoms and preserved functional status, or could be near end of life, with multiple complex care needs. Efficient triage at PRT referral is crucial to match patients with an appropriate provider and care setting as quickly as possible. Many centres have a dedicated PRT clinic, for which triage occurs by a Palliative Clinical Specialist Radiation Therapist (PCSRT). We performed an English-language literature search of 15 databases, without date limits, based on the PICO framework. After independent screening of titles and abstracts by two authors, relevant full text papers were reviewed. Twenty studies (15 publications and five abstracts) and one government report met inclusion criteria. Studies were published over a 21-year period by investigators from four countries. By identifying bottlenecks, screening out inappropriate referrals, and assessing patients in advance of consult, PSCRT triage decreased wait times by approximately 50%, on average, compared to standard pathways (range 30–82%). Increasing efficiency by pre-booking and coordinating appointments increases patient volumes and optimizes use of resources. A triage PCSRT serving a navigator role improves continuity of care, and in decreasing the number of handoffs, safety as well. Shifting triage to a PCSRT allows multidisciplinary team members to work to their maximum scope. In one clinic, after incorporation of PCSRT triage, use of on-call services decreased, as more patients were seen during daytime appointments, contributing to cost-savings.

可能受益于姑息性放射治疗(PRT)的患者可能处于癌症旅程的不同阶段:他们可能症状轻微,功能状态保持不变,或者可能接近生命终点,有多种复杂的护理需求。PRT转诊时的有效分诊对于尽快将患者与合适的提供者和护理环境相匹配至关重要。许多中心都有专门的PRT诊所,由姑息性临床专家放射治疗师(PCSRT)进行分诊。基于PICO框架,我们对15个数据库进行了英语文献检索,没有日期限制。在两位作者对标题和摘要进行独立筛选后,对相关全文论文进行了审查。20项研究(15份出版物和5份摘要)和一份政府报告符合纳入标准。来自四个国家的研究人员发表了历时21年的研究报告。通过识别瓶颈、筛选不合适的转诊,并在咨询前评估患者,与标准途径(30-82%)相比,PSCRT分诊平均减少了约50%的等待时间。通过预先预约和协调预约来提高效率,可以增加患者数量并优化资源使用。分诊PCSRT起到导航作用,提高了护理的连续性,减少了交接次数,也提高了安全性。将分诊转移到PCSRT可以让多学科团队成员最大限度地工作。在一家诊所,在纳入PCSRT分诊后,由于在日间预约期间看到了更多的患者,呼叫服务的使用减少,从而节省了成本。
{"title":"Triage for palliative radiotherapy by clinical specialist radiation therapists: A scoping review","authors":"Pamela Paterson ,&nbsp;Alysa Fairchild","doi":"10.1016/j.tipsro.2023.100213","DOIUrl":"10.1016/j.tipsro.2023.100213","url":null,"abstract":"<div><p>Patients who could benefit from palliative radiotherapy (PRT) may be in different phases of the cancer journey: they may have minimal symptoms and preserved functional status, or could be near end of life, with multiple complex care needs. Efficient triage at PRT referral is crucial to match patients with an appropriate provider and care setting as quickly as possible. Many centres have a dedicated PRT clinic, for which triage occurs by a Palliative Clinical Specialist Radiation Therapist (PCSRT). We performed<!--> <!-->an English-language literature search of 15 databases, without date limits, based on the PICO framework. After independent screening of titles and abstracts by two authors, relevant full text papers were reviewed. Twenty studies (15 publications and five abstracts) and one government report met inclusion criteria. Studies were published over a 21-year period by investigators from four countries. By identifying bottlenecks, screening out inappropriate referrals, and assessing patients in advance of consult, PSCRT triage decreased wait times by approximately 50%, on average, compared to standard pathways (range 30–82%). Increasing efficiency by pre-booking and coordinating appointments increases patient volumes and optimizes use of resources. A triage PCSRT serving a navigator role improves continuity of care, and in decreasing the number of handoffs, safety as well. Shifting triage to a PCSRT allows multidisciplinary team members to work to their maximum scope. In one clinic, after incorporation of PCSRT triage, use of on-call services decreased, as more patients were seen during daytime appointments, contributing to cost-savings.</p></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/81/5b/main.PMC10511840.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41132104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Technical Innovations and Patient Support in Radiation Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1